Medical experts divided on whether 2nd FDA-approved Alzheimer’s drug provides a benefit
But doctors and health experts are divided on whether it warranted an accelerated FDA approval. While some of them have
Category: Alzheimer’s
Alzheimer’s treatment: Patients would pay up to $26,500 per year for Leqembi
The new Alzheimer’s treatment Leqembi will cost an estimated $26,500 per year, according to Eisai, the company that led the
Continue readingAlzheimer’s treatment: Patients would pay up to $26,500 per year for Leqembi
Alzheimer’s drug lecanemab receives accelerated FDA approval amid safety concerns | CNN
Lecanemab will be marketed as Leqembi, the FDA statement said. It has shown “potential” as an Alzheimer’s disease treatment by
FDA Approves, Leqembi, New Treatment for Early Alzheimer’s – The New York Times
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still,
Continue readingFDA Approves, Leqembi, New Treatment for Early Alzheimer’s – The New York Times
FDA controversy over Biogen’s Alzheimer’s drug Aduhelm, explained
Investigators found “atypical collaboration” between the company and the FDA, saying the federal agency went against its own protocols. The
Continue readingFDA controversy over Biogen’s Alzheimer’s drug Aduhelm, explained
FDA under fire over approval of Alzheimer’s drug Aduhelm | US news | The Guardian
US drug regulators failed to follow their own guidance and practices when they approved the controversial Alzheimer’s drug Aduhelm, a
Continue readingFDA under fire over approval of Alzheimer’s drug Aduhelm | US news | The Guardian
New Biomarker Test Can Detect Alzheimer’s Neurodegeneration in Blood – Neuroscience News
Summary: A newly developed blood test can detect brain-derived tau (BD-tau), a biomarker of Alzheimer’s disease neurodegeneration. Source: University of Pittsburgh A
Alzheimer’s Mystery Solved: “Angry” Immune Cells in Brain and Spinal Fluid Identified As Culprit
Cerebrospinal fluid immune system is drastically altered in individuals with cognitive impairment Discovery could potentially be used to treat inflammation
Stranded Dolphins Show Signs of Alzheimer’s Disease in Their Brains : ScienceAlert
Scientists have discovered markers of Alzheimer’s disease in the brains of three different species of dolphin found deceased, stranded onshore. Evidence of mass
Continue readingStranded Dolphins Show Signs of Alzheimer’s Disease in Their Brains : ScienceAlert
Will you get Alzheimer’s in the future? Miami UM tool predicts risk | Miami Herald
Researchers at the University of Miami Miller School of Medicine have developed a new tool they say will help fill
Continue readingWill you get Alzheimer’s in the future? Miami UM tool predicts risk | Miami Herald